[PHARM] Drugs for Movement Disorders [Kruse] Flashcards

B. Parkinson Disease

C. Substantia nigra
How can individuals with parkinsons disease be treated?
Agents that activate dopamine receptors
and/or
Block muscarinic receptors


B. Carbidopa
What is carbidopa?
DOPA decarboxylase inhibitor
It does NOT cross the blood-brain barrier
It overall increases the half life, plasma levels and levodopa available for entry into the brain —–> This REDUCES the daily requirements of levodopa

D. Multiple episodes of immboility per day

E. Tolcapone

A. Hepatotoxicity

C. On-off phenomenon

B. Apomorphine
(Only injectable)

B. Dopamine (D2)
Apomorphine is a DA agonist

A. Amantadine

B. To help correct further the dopamine-ACh imbalance that accounts for parkinsonian signs and symptoms

C. Add benztropine